Guido Giordano

13PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 16, 2026
Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real-world study.

|Jan 25, 2025
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants.

Michele Milella, Giulia Orsi, Mariacristina di Marco

|Jun 26, 2024
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment.

Guido Giordano, Michele Milella, Matteo Landriscina

|Jun 18, 2024
Androgen receptor, PARP signaling, and tumor microenvironment: the 'perfect triad' in prostate cancer?

Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno

|May 27, 2023
Loss of Primary Cilia Potentiates BRAF/MAPK Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (CROCC) Alterations.

Andrea Remo, Federica Grillo, Luca Mastracci

|May 08, 2023
Pancreatic Enzyme Replacement and Nutritional Support With n ab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer.

Guido Giordano, Raffaele Ivan Cincione, Francesca Losavio

Pageof 3

Frequent Collaborators

4 joint publications

Massimo Pancione

3 joint publications

Pietro Parcesepe

3 joint publications

Sara Lonardi

3 joint publications

Elisa Giommoni